tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT

Compare Immunovant (IMVT) vs. Competitors

927 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Immunovant
$24.61
$5.01B
-10.43
71.02%
10 Buy
2 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$103.75
$6.62B
-42.66
140.11%
10 Buy
1 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$38.41
$4.02B
-8.91
45.60%
8 Buy
0 Hold
0 Sell
Strong Buy
Mirum Pharmaceuticals
$95.65
$5.77B
-169.72
133.29%
9 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$85.10
$6.95B
-21.09
286.64%
17 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$17.08
$1.23B
-3.74
-50.89%
11 Buy
2 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMVT
Immunovant
24.61
9.71
65.17%
PTGX
Protagonist Therapeutics
103.75
61.18
143.72%
CRNX
Crinetics Pharmaceuticals
38.41
10.75
38.86%
MIRM
Mirum Pharmaceuticals
95.65
54.18
130.65%
KYMR
Kymera Therapeutics
85.10
61.15
255.32%
MLTX
MoonLake Immunotherapeutics
17.08
-18.90
-52.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts